Paratek Pharmaceuticals - 3 Year Dividend History | PRTK

Historical dividend payout and yield for Paratek Pharmaceuticals (PRTK) since 2016. The current TTM dividend payout for Paratek Pharmaceuticals (PRTK) as of December 13, 2019 is $0.00. The current dividend yield for Paratek Pharmaceuticals as of December 13, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.109B $0.017B
Paratek Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapeutics that treat infectious disease agents. The Company's lead product candidate, omadacycline, is a tetracycline-derived antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. Its second product candidate, WC 3035 is a tetracycline-derived compound designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals, Inc., formerly known as Transcept Pharmaceuticals, Inc., is based in United States.
Stock Name Country Market Cap PE Ratio